Cognitive Task Sensitivity in Perimenopause and Nutritional Status

The study will employ a cross-sectional design. Sixty participants will be recruited (30 participants will be recruited who report being severely affected by cognition-related/brain fog symptoms and 30 participants will be recruited who do not report being severely affected).

Interested participants will follow a link to the study information and consent and will then answer the eligibility questions, including questions about medication/supplementation. Participants are directed to contact the researchers before continuing should any of their answers suggest they may not be eligible to participate. Demographic data will be collected and participants will then complete the Menopause Rating Scale (MRS), followed by the Brain Fog Scale (BFS) and a question asking specifically about how much they are currently affected by brain fog as a result of perimenopause. They will also complete a shortened version of the Adapted Muscle-Strengthening Exercise Questionnaire (A-MSEQ).

Following this participants will be auto directed by a separate link to Cognimapp (a web-based platform for cognitive and mood assessments that can be accessed via a mobile device) where they will complete a brief training session, after which they will complete a full run through of the cognitive tasks.

Once the cognitive tasks have been completed participants will be redirected to a second Qualtrics survey to complete the food frequency questionnaire (EPIC FFQ). Participants will then receive an online debrief and be redirected to a final questionnaire to capture their email address so that they may be compensated £20.

Inclusion criteria

• Aged 40-55 years
• Self-assess as healthy
• Experienced troublesome perimenopause symptoms for at least the past 6 months (as assessed by the Menopause Rating Scale)
• Not post-menopause (defined as 12 months with no periods)
• Non-smoker (including vaping)
• Not lactating or pregnant (or seeking pregnancy)
• Oral contraception and hormone replacement therapy allowed if taken for at least 3 months prior
• Cognitive symptoms/brain fog are not required for participation

Exclusion criteria

• Post-menopause (12 months with no periods)
• Medically induced perimenopause symptoms
• Antidepressant/antianxiety medication or other medication likely to affect cognition in the past 6 months
• Receiving gender-affirming hormone therapy
• Nutritional supplementation (apart from vitamin D) within the last month (more than 3 consecutive days or 4 total)